Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial.
Maryam Sadat PaknejadAzadeh ZareiSamaneh SoleymaniSaeidreza JamalimoghadamsiahkaliAsmaa AsadiMohsen ShatiMohieddin JafariHassan RezadoostGholamreza KordafsharAyeh NaghizadehRaefeh MardiParva NamiranianSeyed Peyman KhamechiNarges AnsariMohammad Sadegh Adel MehrabanHananeh AliakbarzadehMahnaz KhanaviNiusha EsmaealzadehAlireza MoravvejiMehrdad SalahiMaryam KhoiReza RazzaghiHamid Reza BanafsheMostafa AlizadehMarzieh AkhbariMina AtharizadehAkram IzadikhahMahin ElsaghMahdi Hossein Zade GhahnaviehFatemeh EghbalianAzam VanaiHossein IzadiSeyed Ali Al-Hadi MoravejSeyede Ferdos JazayeriHouman BayatHamid Emadi KoochakArman ZargaranPublished in: Phytotherapy research : PTR (2021)
Persian medicine has recommended clinical experiences and proper herbal remedies for prevention and treatment of microbial infections and respiratory diseases. An open-label, randomized, controlled, multicenter trial was conducted at five hospitals in Tehran and Isfahan provinces of Iran on 358 hospitalized adult patients. A total of 174 patients received standard care and 184 received herbal remedies (polyherbal decoction every 8 hr and two herbal capsules every 12 hr) plus standard care for 7 days. The primary clinical endpoint was the duration of hospital stay, and secondary outcomes were clinical improvement of symptoms based on self-assessment questionnaire. Results demonstrated that these natural decoction and capsules treatment plus routine care significantly decreased duration of hospital dyspnea (3.291 day vs. 6.468 days), accelerated clinical improvement, and decreased symptoms such as dry cough, dyspnea, muscle pain, headache, fatigue, anorexia, chills, runny nose, sputum cough, and vertigo in the treatment group compared with standard-care group. Significant effects of these polyherbal formulations on improving the symptoms of COVID-19 could be incredibly promising for managing this pandemic with acceptable tolerability.
Keyphrases
- healthcare
- palliative care
- quality improvement
- pain management
- sars cov
- coronavirus disease
- double blind
- end stage renal disease
- affordable care act
- phase iii
- emergency department
- cross sectional
- sleep quality
- metabolic syndrome
- chronic kidney disease
- newly diagnosed
- skeletal muscle
- randomized controlled trial
- advanced cancer
- study protocol
- acute care
- peritoneal dialysis
- placebo controlled
- combination therapy
- physical activity
- minimally invasive
- pet ct
- drug induced
- health insurance
- prognostic factors
- clinical practice
- smoking cessation